ClinicalTrials.gg
RecruitingNCT03318432Updated Oct 2, 2025

Stroke Recovery Initiative - Registry for Stroke Research Studies

An observational study in Stroke, Acute Stroke and Ischemic Stroke, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-02.

Sponsored by University of California, San Francisco · Observational

From the registry’s dates

  • Started Feb 2013; still recruiting 13 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
60,000
Ages
18 Years and older
Sex
All
01

Study summary

The Stroke Recovery Initiative is a nation-wide participant recruitment registry that connects people who have had a stroke with researchers who are working to develop new approaches to improve recovery after stroke.

Read the detailed description

The Stroke Recovery Initiative at UCSF is designed to help people who have had a stroke to connect with researchers who are applying the latest science and technology to develop new treatments for stroke recovery. Anyone who is 18 years of age or older and has had a stroke may submit a survey to join. The self-reported information on the survey will be used to match participants to current or future stroke research studies and study personnel for each specific study may contact participants for further screening. Some studies are recruiting participants nationally, not just in the San Francisco Bay Area.

02

Conditions studied

  • Stroke
  • Acute Stroke
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Subarachnoid Hemorrhage
  • Cerebral Ischemia
  • Cerebral Infarction
  • Cerebral Stroke
  • Cerebral Vascular Accident

Keywords

  • Stroke
  • Acute Stroke
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Cerebral Ischemia
  • Cerebral Infarction
  • Cerebral Stroke
  • Cerebral Vascular Accident
  • Stroke Recovery
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 60,000 is above the median of 152 across 1,968 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,169 studies on the registry; 372 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 202 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stroke survivors

Eligibility criteria

  • 18 years of age or older
  • Have suffered a stroke
  • Have ongoing symptoms as a result of the stroke
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
60,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Total Enrollment

    Total Number of Participants in the Registry

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2013 (actual). Primary completion is estimated for Sep 2028, 187 months after the start.

Of 835 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 187 months is above that.

Counting every sponsor, half of 897 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2017
First posted
Oct 23, 2017
StartActual
Feb 9, 2013
Primary completionEst.
Sep 2028
CompletionEst.
Sep 2028
Last update
Oct 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03318432
Responsible party
Sponsor
First posted
Oct 23, 2017
Start date
Feb 9, 2013
Primary completion
Sep 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Oct 2, 2025

Study contacts

Emerald Wan
Contact
strokerecoveryinitiative@ucsf.edu
415-353-2194
Anthony S. Kim, MD, MAS
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion